Detalhe da pesquisa
1.
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
Diabetes Obes Metab
; 26(6): 2412-2421, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558508
2.
Commentary: SGLT inhibitors in type 1 diabetes: Place in therapy and a risk mitigation strategy for preventing diabetic ketoacidosis - the STOP DKA protocol.
Diabetes Obes Metab
; 21(10): 2189-2191, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31334593
3.
Major Update: Masks for Prevention of SARS-CoV-2 in Health Care and Community Settings.
Ann Intern Med
; 176(12): eL230358, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109756
4.
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial.
Diabetes Obes Metab
; 20(9): 2229-2237, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761615
5.
Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.
Diabetologia
; 59(2): 266-74, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26577795
6.
Screening for familial and hereditary prostate cancer.
Int J Cancer
; 138(11): 2579-91, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26638190
7.
Comparison of vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment: a randomised clinical trial.
Diabetologia
; 58(9): 2020-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26067186
8.
Lessons learned from early-stage clinical trials for diabetic nephropathy.
Expert Opin Investig Drugs
; 33(4): 287-301, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38465470
9.
Obesity and diabetes: the final frontier.
Expert Rev Endocrinol Metab
; 18(1): 81-94, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710450
10.
The effect of vasoactive agents on post-pressure hyperemia.
Microvasc Res
; 84(3): 345-50, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22835521
11.
Ethical dilemma of mandated contraception in pharmaceutical research at catholic medical institutions.
Am J Bioeth
; 12(7): 34-7, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22694032
12.
Skin blood flow abnormalities in diabetic dermopathy.
J Am Acad Dermatol
; 65(3): 559-563, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21531041
13.
Pharmacotherapeutic options for prediabetes.
Expert Opin Pharmacother
; 22(1): 45-54, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32892663
14.
Current and emerging gluconeogenesis inhibitors for the treatment of Type 2 diabetes.
Expert Opin Pharmacother
; 22(16): 2167-2179, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348528
15.
The time to develop treatments for diabetic neuropathy.
Expert Opin Investig Drugs
; 30(2): 119-130, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423557
16.
The time to offer treatments for COVID-19.
Expert Opin Investig Drugs
; 30(5): 505-518, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721548
17.
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.
AIDS Rev
; 23(1): 40-47, 2021 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556957
18.
Skin blood flow in patients with stage 5 chronic kidney disease on hemodialysis.
J Ren Nutr
; 20(5 Suppl): S89-94, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20797579
19.
Premix insulins in type 1 diabetes: the coming of degludec/aspart.
Expert Opin Drug Metab Toxicol
; 15(4): 341-348, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30789066
20.
The journey from gene knockout to clinical medicine: telotristat and sotagliflozin.
Drug Des Devel Ther
; 13: 817-824, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880915